ACT Advisors
LLY icon

ACT Advisors’s Eli Lilly LLY Stock Holding History

ACT Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$539K Buy
466
+79
+20% +$93.2K 0.18% 39
2026
Q2 		$465K Buy
387
+38
+11% +$38.8K 0.15% 41
2026
Q1 		$321K Buy
349
+23
+7% +$23.3K 0.14% 52
2025
Q4 		$351K Buy
326
+40
+14% +$38.2K 0.14% 46
2025
Q3 		$218K Sell
286
-38
-12% -$28.3K 0.09% 58
2025
Q2 		$253K Buy
324
+14
+5% +$10.9K 0.12% 47
2025
Q1 		$256K Sell
310
-8
-3% -$6.66K 0.14% 43
2024
Q4 		$246K Buy
318
+40
+14% +$33.1K 0.13% 42
2024
Q3 		$246K Buy
278
+14
+5% +$12.6K 0.12% 40
2024
Q2 		$239K Buy
+264
New +$211K 0.12% 39

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
Sapient Capital
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Goelzer Investment Management
Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return
Private Capital Advisors
Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Weatherly Asset Management
Weatherly Asset Management Del Mar, California $1.42B AUM 33.31% 1-Year Est. Return

ACT Advisors's LLY Position: Q3 2026 in Review

ACT Advisors increased its Eli Lilly (LLY) stake by 20% in Q3 2026, buying an estimated $93.2K and bringing the position to 466 shares worth $539K. The position accounts for 0.18% of the portfolio, ranked #39.

ACT Advisors first reported a position in LLY in Q2 2024 and has held it in 10 quarters since. 1,223 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • ACT Advisors held 466 shares of Eli Lilly worth $539K as of Q3 2026.
  • ACT Advisors bought 79 Eli Lilly shares in Q3 2026, an estimated $93.2K.
  • Eli Lilly made up 0.18% of ACT Advisors's portfolio in Q3 2026, its #39 holding.
  • ACT Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 10 quarters since.
  • 1,223 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on ACT Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.